Press release - 09/01/2012 EU: "Virtual liver" technology helps detect liver tumours Scientists and surgeons from France, Germany, United Kingdom and Switzerland have developed a "virtual liver", using EU research funding, which will help surgeons better plan and carry out tumour operations and ensure quicker patient recovery. The PASSPORT project (Patient-Specific Simulation and Pre-Operative Realistic Training) makes a uniquely accurate "virtual liver" available to physicians based on medical images sent by…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/eu-virtual-liver-technology-helps-detect-liver-tumours
Press release - 20/12/2011 Ten years BioRegio STERN - an interim result BioRegion STERN is one of the largest and most successful bio-regions in Germany. Its unique selling point is its mix of 120 small and medium-sized medtech companies and 100 up-and-coming biotech enterprises. Around 2,200 staff work in the region's biotech companies alone, representing growth of 30 percent in the past three years. Jobs in the life sciences industry have long been regarded as an engine of growth. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/ten-years-bioregio-stern-an-interim-result
Article - 06/12/2011 Bridging the gap between academia and industry Prof. Dr. Katja Schenke-Layland divides her work equally between the Stuttgart-based Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, where she is the deputy head of the Department of Cell Systems, and the University Hospital in Tübingen where she teaches and researches the use of biomaterials in the field of regenerative medicine at the Department of Thoracic, Cardiac and Vascular Surgery. By working between the two…https:////www.gesundheitsindustrie-bw.de/en/article/news/bridging-the-gap-between-academia-and-industry
Press release - 07/11/2011 Third quarter: HARTMANN increases sales in all business segments The HARTMANN GROUP continued its growth despite the difficult conditions in the health markets. Global sales revenues increased by 5.0 percent to EUR 1,263.8 million compared to the previous year.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/third-quarter-hartmann-increases-sales-in-all-business-segments
Article - 10/10/2011 Meet & Match in the BioValley – bringing together international partners Small life sciences companies find it particularly difficult to set aside time for making international contacts at trade fairs. The BioValley cluster located in a region bordered by Germany France and Switzerland has a team of scouts that focus on matchmaking. Dr. Mona Boy is the coordinator of the trinational matchmaking team of the BioValley cluster.https:////www.gesundheitsindustrie-bw.de/en/article/news/meet-match-in-the-biovalley-bringing-together-international-partners
Dossier - 10/10/2011 Global players in theory but not always in practice Biotechnology companies have always had international ties: they employ cutting-edge technologies and market the discoveries and developments of researchers around the world. Rapid innovation cycles and rapid technological developments force companies to undertake costly R&D as well as market their products and/or services across national borders.https:////www.gesundheitsindustrie-bw.de/en/article/dossier/global-players-in-theory-but-not-always-in-practice
Press release - 30/09/2011 Blood Vessels from Your Printer Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
Dossier - 19/09/2011 Social media are gaining in importance in the life sciences Social network services are springing up like mushrooms; everybody seems to be talking about ‘Web 2.0’ or ‘Podcast’. The life sciences are also starting to use the new communication media for their purposes. Social network services are online platforms with a representation of each individual user who links up with a number of different social networks composed of other users. Terms like Web 2.0 and Podcast are commonly used and the World Wide…https:////www.gesundheitsindustrie-bw.de/en/article/dossier/social-media-are-gaining-in-importance-in-the-life-sciences
Press release - 02/09/2011 German Government starts the initiative "Health - Made in Germany" The overall aim of the initiative is to exploit the dormant capacities that lie within the export of health care products made in Germany. In Germany, many companies are already world leaders in their fields, in part due to a policy of consistent and early promotion of health care in Germany. German technology suppliers possess decades of valuable experience in realizing health care projects both at home and abroad. Provider of products and…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/german-government-starts-the-initiative-health-made-in-germany
Press release - 24/08/2011 KIT Researcher Win the Mimics Innovation Awards 2011 in the Category “Innovations in Computer Aided Engineering” The contribution “A Preprocessing Approach for Innovative Patient-Specific Intranasal Flow Simulations” of Krause (EMCL), Gengenbach (EMCL), Mayer (SCC), Zimny (EMCL) and Heuveline (Head of EMCL) has won the Mimics Innovation Awards 2011 in the category 2 “Innovations in computer aided engineering” which is associated with a prize of 5,000 Euro.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/kit-researcher-win-the-mimics-innovation-awards-2011-in-the-category-innovations-in-computer-aided-e
Article - 22/08/2011 IHB – Textile research that leads to new applications Innovative medical textiles can offer clear advantages when it comes to improvements in delivering modern health care systems. The Institute for Hygiene and Biotechnology (IHB) at the Hohenstein Institute is currently involved in the development of new fibre-based materials for successful applications in the private and public health sectors. Both natural biopolymers and stem cells have the potential of becoming part of such medical products of…https:////www.gesundheitsindustrie-bw.de/en/article/news/ihb-textile-research-that-leads-to-new-applications
Article - 29/07/2011 Labor Dr. Merk und Kollegen - Viruses under control It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.https:////www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
Press release - 28/07/2011 Big ideas can also be small BioRegio STERN Management GmbH honoured the winners of the regional “Science2Start” ideas competition on July 21. The three victors from Stuttgart, Tübingen and Reutlingen celebrated their success together with over 300 guests at a joint summer reception organised by BioRegio STERN Management GmbH, PUSH! (the partner network for new companies founded by academics at Stuttgart universities), the Society for the Promotion of Biotechnology and…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/big-ideas-can-also-be-small
Article - 04/07/2011 The use of regenerative biomaterials is likely to grow Tuttlingen-based Aesculap AG is committed to using different materials including ceramics, titanium and high-performance polymers for the development and production of implants. The medical technology company has come up with a solution to prevent people from developing allergies against substances used in prostheses. Dr. Harald Stallforth, CEO Research & Development and Vice Chairman of the Aesculap AG management board talks with a BioLAGO…https:////www.gesundheitsindustrie-bw.de/en/article/news/the-use-of-regenerative-biomaterials-is-likely-to-grow
Dossier - 04/07/2011 Implants of the future: bioactive, corrosion-resistant and antibacterial People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…https:////www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
Article - 04/07/2011 Orthobion GmbH: biomaterials for spinal implants If one takes a closer look at the mechanisms involved in bone growth, it turns out that the supposedly simple issue as to how bones grow cannot be fully answered. Konstanz-based Orthobion GmbH investigates and produces targeted biomaterials for use in implants designed for the treatment of spinal column defects. The surface structures of materials and how they affect the adhesion of bones to implant surfaces are key issues in the production of…https:////www.gesundheitsindustrie-bw.de/en/article/news/orthobion-gmbh-biomaterials-for-spinal-implants
Article - 06/06/2011 Knowledge transfer depends on the application of learning The ability of scientists from different disciplines to understand each other as well as excellent communication skills play an ever-increasing role in the transfer of knowledge from academic research to industry. Vice president of research at the Konstanz University of Applied Sciences HTWG Professor Gunter Voigt explains how academia and industry work together and also highlights the conditions that are necessary for such cooperations to lead…https:////www.gesundheitsindustrie-bw.de/en/article/news/knowledge-transfer-depends-on-the-application-of-learning
Dossier - 30/05/2011 Knowledge and technology transfer as a social responsibility Technology transfer that efficiently exploits the intellectual property created by publicly funded research is necessary in order to turn scientific discoveries into successful innovations that improve people’s quality of life and boost the economy. The efforts made to rapidly transfer research results from the laboratory into clinical application for the benefit of patients leads to new strategic partnerships and structures in the field of…https:////www.gesundheitsindustrie-bw.de/en/article/dossier/knowledge-and-technology-transfer-as-a-social-responsibility
Article - 30/05/2011 Technology Licensing Office (TLB): invention and patent management The Technology Licensing Office TLB works in partnership with science and industry and is continuously coming up with new ways to ensure the economic success of inventions from all the key fields of technology. Dr. Frank Schlotter head of Life Sciences at the Karlsruhe-based TLB provides insights into the work that his office does taking as examples innovations from the fields of regenerative medicine and diagnostics.https:////www.gesundheitsindustrie-bw.de/en/article/news/technology-licensing-office-tlb-invention-and-patent-management
Article - 16/05/2011 Oliver Röhrle and the biomechanics of the musculo-skeletal system Dr. Oliver Röhrle contributes to the excellent standards in the field of biomechanics at the University of Stuttgart. He has held one of the popular junior professorships in the Simulation Technology (SimTech) cluster of excellence since 2008 and has recently received a research prize for his work on the biomechanics of the musculo-skeletal system.https:////www.gesundheitsindustrie-bw.de/en/article/news/oliver-roehrle-and-the-biomechanics-of-the-musculo-skeletal-system
Article - 02/05/2011 Production of high-density peptide arrays Frank Breitling and Alexander Nesterov-Müller from the Karlsruhe Institute of Technology KIT are working on the development of a second-generation peptide laser printer and a peptide chip printer based on computer chips. This development will enable the low-cost production of high-density peptide arrays consisting of up to one million peptides as well as opening up completely new areas of application.https:////www.gesundheitsindustrie-bw.de/en/article/news/production-of-high-density-peptide-arrays
Press release - 25/04/2011 Aesculap posts further growth Aesculap a provider of devices and services for surgical and interventional procedures in operative medicine achieved record sales in 2010. Sales rose to 1.28 billion euros 11 hot on the heels of a sales growth of 5 per cent during the global financial crisis in 2009. In order to meet market demand Aesculap increased the staff at its Tuttlingen site to 3000 up 200. Based on the first quarter figures that show a sales increase of 11.6 per cent…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/aesculap-posts-further-growth
Article - 18/04/2011 Can tissue be glued together in a non-invasive way? At present, the use of substances to glue tissue together is only an idea, but it might eventually mean that surgeons will no longer need to use a needle and thread. The cellular and molecular biologist Rainer Wittig from the Ulm-based ILM hopes to develop such substances using a photochemical process. He is also planning to test substances that not only adhere to tissue but which will also be able to initiate the wound healing process.https:////www.gesundheitsindustrie-bw.de/en/article/news/can-tissue-be-glued-together-in-a-non-invasive-way
Article - 10/04/2011 Wilhelm Aicher is committed to regenerative medicine research Laboratory-based regeneration of human cartilage and muscle tissue is his strong suit: Prof. Dr. Wilhelm K. Aicher brings his expertise in cellular and molecular biology to research focusing on the development of innovative therapies for the treatment of tissue damage. Successes such as a knee cartilage made from autologous (patients’ own) cells show that Aicher is on the right track.https:////www.gesundheitsindustrie-bw.de/en/article/news/wilhelm-aicher-is-committed-to-regenerative-medicine-research
Press release - 06/04/2011 Pulse of the Industry Auditors Ernst & Young presented its latest "Pulse of the Industry" medical technology report as guests of BioRegio STERN Management GmbH and the Medical Valley Hechingen Academy at the Villa Eugenia in Hechingen on Wednesday, 30 March. The annual report provides figures and detailed analyses on the performance of an industry that continues to be highly successful, yet needs to face up to new challenges. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/pulse-of-the-industry